University of Washington scientists Matt Kaeberlein, with his dog Dobby, left, and Dan Promislow, with Frisbee, hope to launch a study of the anti-aging drug rapamycin in dogs.
University of Washington scientists Matt Kaeberlein, with his dog Dobby, left, and Dan Promislow, with Frisbee, hope to launch a study of the anti-aging drug rapamycin in dogs. Steve Ringman Tribune
University of Washington scientists Matt Kaeberlein, with his dog Dobby, left, and Dan Promislow, with Frisbee, hope to launch a study of the anti-aging drug rapamycin in dogs. Steve Ringman Tribune

Scientists dig into key to extend dogs’ lives

December 23, 2014 07:37 PM